Martin CK, Rosenbaum D, Han H, Geiselman PJ, Wyatt HR, Hill JO, et al
Williams broke her silence about her weight loss journey, revealing she used medication to help her lose 31 pounds
Neuroprotective effects of GLP-1 class drugs in Parkinsons disease
Clinical trials have demonstrated semaglutide effectiveness for weight management, with an average of 15 percent body weight lost after 52 weeks of treatment in obese and overweight patients who had no history of diabetes, hypertension or cardiovascular disease
The challenge is that semaglutide, tirzepatide, and similar medications reduce appetite by 20 to 40 percent within weeks, making the old strategy of eating a large chicken breast or a 16-ounce steak nearly impossible